Dendritic Cell Based PSMA Immunotherapy for Prostate Cancer Using a CD40-Targeted Adenovirus Vector

Overview of attention for article published in PLOS ONE, October 2012

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 47 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

DENDRITIC CELL TARGETED ADENOVIRUS FOR VACCINATION

Application WO-2018201017-A1

World Intellectual Property Organisation (WIPO)